LYVE1 and cancer: TOSICA attention scores reveal that ESCA separates from other cancers in cytokine signaling and insulin signaling pathway (Fig. 4e), hinting at higher inflammatory state of LYVE1+ RTMs in ESCA, which was not observed in the original study.